HMI-102-101: A Phase 1/2 Open-Label, Randomized, Concurrently-Controlled, Dose Escalation Study to Evaluate the Safety and Efficacy of HMI-102 in Adult PKU Subjects with PAH Deficiency

Project: Research project

Project Details

StatusActive
Effective start/end date7/9/198/31/50

Funding

  • Homology Medicines, Inc.